Quick answers
- What is Herceptin?
- Herceptin is a brand name of Trastuzumab, a prescription medicine. The FDA NDC Directory lists 1 Herceptin product in 1 strength and form.
- Who makes Herceptin?
- Genentech holds the FDA application for Herceptin (BLA103792, approved September 25, 1998).
- Is there a generic or store brand of Herceptin?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Herceptin product. Ask your pharmacist whether one is right for you.
- Has Herceptin been recalled?
- No recall linked to Herceptin products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Herceptin is
Each Herceptin product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Trastuzumab · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| trastuzumab 150 mg/7.4 mL injection, powder, lyophilized, for solution (intravenous) | Herceptin | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Trastuzumab →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA103792 | Genentech | September 25, 1998 | 1 |
Companies that list Herceptin
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Herceptin products.
- Genentech, Inc.1 product
Recalls
No recall linked to Herceptin products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.